CD8 expression allows T cell signaling by monomeric peptide-MHC complexes

Immunity

Volumn 9, Issue 4, 1998, Pages 467-473

  Delon, Jérôme ^a   Grégoire, Claude ^b   Malissen, Bernard ^b   Darche, Sylvie ^b   Lemaître, Fabrice ^b   Kourilsky, Philippe ^b   Abastado, Jean Pierre ^b   Trautmann, Alain ^a  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; COMPLEX FORMATION; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0032192470     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80630-5     Document Type: Article

References (56)

1. Abastado, J.-P., Casrouge, A., and Kourilsky, P. (1993). Differential role of conserved and polymorphic residues of the binding groove of MHC class I molecules in the selection of peptides. J. Immunol. 151, 3569-3575.
2. Abastado, J.-P., Lone, Y.-C., Casrouge, A., Boulot, G., and Kourilsky, P. (1995). Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182, 439-447.
3. Anderson, P., Blue, M.-L., Morimoto, C., and Schlossman, S.F. (1987). Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. J. Immunol. 139, 678-682.
4. Arden, B. (1998). Conserved motifs in T-cell receptor CDR1 and CDR2: implications for ligand and CD8 co-receptor binding. Curr. Opin. Immunol. 10, 74-81.
5. Blanc, D., Bron, C., Gabert, J., Letourneur, F., MacDonald, H.R., and Malissen, B. (1988). Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants. Eur. J. Immunol. 18, 613-619.
6. Braciale, T.J., Braciale, V.L., Winkler, M., Stroynowski, I., Hood, L., Sambrook, J., and Gething, M.-J. (1987). On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J. Exp. Med. 166, 678-692.
7. Brown, J.H., Jardetsky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1993). Three-dimensional structure of human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
8. lck is required for early T cell signalling events. EMBO J. 10, 1201-1207.
9. Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden, B., and Chien, Y. (1998). Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16, 523-544.
10. 2+ response. Eur. J. Immunol. 28, 716-729.
11. 2+ responses triggered in T cells by dendritic cells compared with B cells. J. Exp. Med. 188, in press.
12. Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., and Wiley, D.C. (1998). Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8, 403-411.
13. Donnadieu, E., Bismuth, G., and Trautmann, A. (1992). Calcium fluxes in T lymphocytes. J. Biol. Chem. 267, 25864-25872.
14. Dustin, M.L., Ferguson, L.M., Chan, P.Y., Springer, T.A., and Golan, D.E. (1996). Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J. Cell. Biol. 132, 465-474.
15. Gabert, J., Langlet, C., Zamoyska, R., Parnes, J.R., Schmitt-Verhulst, A.-M., and Malissen, B. (1987). Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes. Cell 50, 545-554.
16. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
17. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996a). An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
18. Garcia, K.C., Scott, C.A., Brunmark, A., Carbone, F.R., Peterson, P.A., Wilson, I.A., and Teyton, L. (1996b). CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384, 577-581.
19. Germain, R.N. (1997). T cell signaling: the importance of receptor clustering. Curr. Biol. 7, R640-R644.
20. Germain, R.N., Levine, E.H., and Madrenas, J. (1995). The T-cell receptor as a diverse signal transduction machine. Immunologist 3/4, 113-121.
21. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64, 511-520.
22. Grégoire, C., Lin, S.-Y., Mazza, G., Rebaï, N., Luescher, I.F., and Malissen, B. (1996). Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex. Proc. Natl. Acad. Sci. USA 93, 7184-7189.
23. Hoeveler, A., and Malissen, B. (1993). The cysteine residues in the cytoplasmic tail of CD8α are required for its coreceptor function. Mol. Immunol. 30, 755-764.
24. Irie, H.Y., Mong, M.S., Itano, A., Crooks, M.E., Littman, D.R., Burakoff, S.J., and Robey, E. (1998). The cytoplasmic domain of CD8β regulates Lck kinase activation and CD8 T cell development. J. Immunol. 161, 183-191.
25. Kessler, B., Hudrisier, D., Cerrotini, J.-C., and Luescher, I.F. (1997). Role of CD8 in aberrant function of cytotoxic T lymphocytes. J. Exp. Med. 186, 2033-2038.
26. König, R., Shen, X., and Germain, R.N. (1995). Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182, 779-787.
27. Ledbetter, J.A., June, C.H., Rabinovitch, P.S., Grossman, A., Tsu, T., and Imboden, J.B. (1988). Signal transduction through CD4 receptors: stimulatory vs inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur. J. Immunol. 18, 525-532.
28. Letourneur, F., Gabert, J., Cosson, P., Blanc, D., Davoust, J., and Malissen, B. (1990). A signaling role for the cytoplasmic segment of the CD8 α chain detected under limiting stimulatory conditions. Proc. Natl. Acad. Sci. USA 87, 2339-2343.
29. lck. Eur. J. Immunol. 28, 745-754.
30. d-restricted cloned CTL specific for a photoreactive peptide derivative. Immunity 3, 51-63.
31. Luescher, I.F., Vivier, E., Layer, A., Mahiou, J., Godeau, F., Malissen, B., and Romero, P. (1995b). CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373, 353-356.
32. Madrenas, J., Chau, L.A., Smith, J., Bluestone, J.A., and Germain, R.N. (1997). The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185, 219-229.
33. Metzger, H. (1992). Transmembrane signaling: the joy of aggregation. J. Immunol. 149, 1477-1487.
34. + T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157, 978-983.
35. Norment, A.M., Salter, R.D., Parham, P., Engelhard, V.H., and Littman, D.R. (1988). Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336, 79-81.
36. + T cell activation. Int. Immunol. 10, 619-630.
37. Qian, D., and Weiss, A. (1997). T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9, 205-212.
38. Rammensee, H.G., Friede, T., and Stevanoviic, S. (1995). MHC ligands and peptide motifs: first listing, Immunogenetics 41, 178-228.
39. Ratcliffe, M.J.H., Coggeshall, K.M., Newell, M.K., and Julius, M.H. (1992). T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor. J. Immunol. 148, 1643-1651.
40. Reich, Z., Boniface, J.J., Lyons, D.S., Borochov, N., Watchel, E.J., and Davis, M.M. (1997). Ligand-specific oligomerization of T-cell receptor molecules. Nature 387, 617-620.
41. Renard, V., Delon, J., Luescher, I.F., Malissen, B., Vivier, E., and Trautmann, A. (1996). The CD8β polypeptide is required for the recognition of an altered peptide ligand as an agonist. Eur. J. Immunol. 26, 2999-3007.
42. Rosenstein, Y., Ratnofsky, S., Burakoff, S.J., and Herrmann, S.H. (1989). Direct evidence for binding of CD8 to HLA class I antigens. J. Exp. Med. 169, 149-160.
43. Sakihama, T., Smolyar, A., and Reinherz, E.L. (1995). Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92, 6444-6448.
44. Sakihama, T., Smolyar, A., and Reinherz, E.L. (1996). Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules, Immunol. Today 16, 581-587.
45. Salter, R.D., Benjamin, R.J., Wesley, P.K., Buxton, S.E., Garrett, T.P.J., Clayberger, C., Krensky, A.M., Norment, A.M., Littman, D.R., and Parham, P. (1990). A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345, 41-46.
46. Sykulev, Y., Joo, M., Vturina, I., Tsomides, T.J., and Eisen, H.N. (1996). Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565-571.
47. Tomonari, K., and Levering, E. (1988). T-cell receptor-specific monoclonal antibodies against a V beta 11-positive mouse T-cell clone. Immunogenetics 28, 445-451.
48. Viola, A., Salio, M., Tuosto, L., Linkert, S., Acuto, O., and Lanzavecchia, A. (1997). Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J. Exp. Med. 186, 1775-1779.
49. Vonakis, B.M., Chen, H., Haleem-Smith, H., and Metzger, H. (1997). The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J. Biol. Chem. 272, 24072-24080.
50. Weis, R.M., Balakrishnan, K., Smith, B.A., and McConnell, H.M. (1982). Stimulation of fluorescence in a small contact region between rat basophil leukemia cells and planar lipid membrane targets by coherent evanescent radiation. J. Biol. Chem. 257, 6440-6445.
51. Wheeler, C.J., von Hoegen, P., and Parnes, J.R. (1992). An immunological role for the CD8 β-chain. Nature 357, 247-249.
52. White, J., Blackman, W.J., Bill, J., Kappler, J., Marrack, P., Gold, D., and Born, W. (1989). Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143, 1822-1825.
53. lck. Immunity 4, 495-504.
54. Wu, H., Kwong, P.D., and Hendrickson, W.A. (1997). Dimeric association and segmental variability in the structure of human CD4. Nature 387, 527-530.
55. Zamoyska, R., Derham, P., Gorman, S.D., von Hoegen, P., Bolen, J.B., Veillette, A., and Parnes, J.R. (1989). Inability of CD8α' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342, 278-281.
56. Zamoyska, R., Vollmer, A.C., Sizer, K.C., Liaw, C.W., and Parnes, J.R. (1985). Two Lyt-2 polypeptides arise from a single gene by alternative splicing patterns of mRNA. Cell 43, 153-163.